Huebner, H., Kurbacher, C. M., Kuesters, G., Hartkopf, A. D., Lux, M. P., Huober, J., . . . Ettl, J. (2020). Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany. BMC Cancer.
Citação norma ChicagoHuebner, Hanna, et al. "Heregulin (HRG) Assessment for Clinical Trial Eligibility Testing in a Molecular Registry (PRAEGNANT) in Germany." BMC Cancer 2020.
Citação norma MLAHuebner, Hanna, et al. "Heregulin (HRG) Assessment for Clinical Trial Eligibility Testing in a Molecular Registry (PRAEGNANT) in Germany." BMC Cancer 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.